Skip to main content
. 2022 Jan 24;12:1278. doi: 10.1038/s41598-022-05376-8

Table 3.

Obstetric outcome between rubella seronegative (n = 6363) versus seropositive (n = 62,669) nulliparous gravidae.

Rubella status p RR (95% CI)
Seronegative Seropositive
Medical history (%) 10.9 12.9  < 0.001 0.847 (0.787–0.911)
Abortion history (%) 40.4 37.5  < 0.001 1.076 (1.043–1.111)
Obstetric complications (%) 20.7 18.8 0.015 1.096 (1.018–1.180)
Gestational hypertension 1.3 1.7 0.023 0.772 (0.617–0.966)
Pre-eclampsia 2.0 1.8 0.268 1.109 (0.924–1.332)
Gestational diabetes 6.2 6.7 0.198 0.937 (0.848–1.035)
Placental abruption 1.2 1.1 0.390 1.107 (0.878–1.395)
Placenta praevia 0.8 0.8 0.645 0.934 (0.700–1.247)
Preterm birth < 37 weeks 6.5 6.6 0.699 0.981 (0.889–1.082)
Post-dated pregnancy 1.7 0.9  < 0.001 1.900 (1.550–2.329)
Labour induction 27.3 28.6 0.037 0.957 (0.917–0.998)
Instrumental vaginal delivery 20.6 20.6 0.971 1.001 (0.939–1.068)
Caesarean section 23.6 22.9 0.216 1.030 (0.983–1.079)
Manual removal of placenta 4.9 3.8  < 0.001 1.270 (1.132–1.426)
Postpartum haemorrhage 3.2 3.6 0.080 0.881 (0.764–1.015)
Infant ≥ 4000 g 2.7 2.0  < 0.001 1.344 (1.147–1.574)
Infant < 2500 g 7.2 7.7 0.150 0.934 (0.852–1.025)
Male infant 51.1 51.7 0.346 0.988 (0.963–1.013)
Apgar score < 7 at 5th min 0.5 0.6 0.532 0.893 (0.626–1.274)
Perinatal mortality 0.4 0.4 0.491 0.861 (0.563–1.318)
Stillbirth 0.2 0.3 0.261 0.733 (0.426–1.262)
Neonatal death 0.1 0.1 0.635 1.182 (0.592–2.359)

Significant differences shown in bold.

Results in %, analysis with chi square test and relative risk (RR) and 95% confidence intervals (CI).